Modulation of [5-125I]iododeoxyuridine incorporation into tumour and normal tissue DNA by methotrexate and thymidylate synthase inhibitors
- 1 August 1996
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (9) , 1603-1608
- https://doi.org/10.1016/0959-8049(96)00117-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Novel Treatments for Liver Cancer and Other Solid Tumors Show Early PromisePublished by American Medical Association (AMA) ,1994
- Selective uptake of toxic nucleoside (125IUdR) by resistant cancerThe British Journal of Radiology, 1991
- In vivo uptake of 131I-5-iodo-2-deoxyuridine by malignant tumours in manBritish Journal of Cancer, 1991
- Ligand-induced Inactivation of Type I Iodothyronine 5′ Deiodinase: Protection by Propylthiouracilin Vivoand Reversibilityin Vitro*Endocrinology, 1989
- Structure-activity relationship of ligands of dihydrouracil dehydrogenase from mouse liverBiochemical Pharmacology, 1989
- 5-Fluorouracil and High-Dose Folic Acid Treatment for Metastatic Colon CancerAmerican Journal of Clinical Oncology, 1987
- Evidence for the existence of covalent nucleotide-thymidylate synthase complexes, identification of site of attachment, and enhancement by folates.Journal of Biological Chemistry, 1986
- Clinical pharmacology of 5-iodo-2′-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulationClinical Pharmacology & Therapeutics, 1985
- A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acidBiochemical Journal, 1956